Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine), MACG (USA), FCPS (Gastroenterology), SCE (U.K)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MACG (USA), FCPS (Gastroenterology), SCE (U.K)
Internal Medicine Specialist
Certified in Diabetology (USA), F.C.P.S (Medicine), M.B.B.S
Internal Medicine Specialist
Certified in Diabetology (USA), F.C.P.S (Medicine), M.B.B.S
Internal Medicine Specialist
MBBS, MD (Internal Medicine)
Internal Medicine Specialist
MBBS, FACP (USA), FCPS (Medicine)
Internal Medicine Specialist
MBBS, MRCP (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship in Diabetes & Endocrine
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship in Diabetes & Endocrine
Gastroenterologist
MBBS, FCPS (Gastroenterology), SCE Gastroenterology (UK), ESB Gastroenterology (EU)
Gastroenterologist
MBBS, FCPS (Gastroenterology), SCE Gastroenterology (UK), ESB Gastroenterology (EU)
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
General Physician
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures